With respect to the critical roles of RIPK1 in inflammation, RIPK1 has been identified as a therapeutic target of monogenic and polygenic autoimmune, inflammatory, neurodegenerative, ischemic and acute conditions, such as sepsis, by the potential applications of RIPK1 inhibitors [84]. The gene discussed is RIPK1; the disease is Sepsis.